Baker’s allergy and asthma prove to be a significant contributor to workplace asthma worldwide. This study uncovered new research on the treatment of baker’s allergy and asthma.
There were documented studies pertaining to regulatory exposure requirements, occupational control mechanisms aimed at reducing flour dust exposures, surveillance programmes (exposure screening, medical surveillance), and workplace records, education, and training programmes.
Detailed awareness of risk factors and detection strategies to evaluate exposure and to identify employees at high risk early, is therefore not optimal as mechanisms for occupational control are rarely multifaceted. The fact that exposure levels for wellbeing are lacking internationally complements this. Monitoring of exposure levels and medical monitoring are essential to preventive strategic efficiency assessments. Triage systems to optimise the performance of medical surveillance programmes are promising, but they require replication in various contexts.
In addition to standardised respiratory questionnaires, the assessment and quantification of serial exhaled nitric oxide (FeNO) measurements must be examined in future studies to complement allergic sensitisation in order to identify baker’s asthma early and to assess the long-term impact of interventions.
Reference: https://journals.lww.com/co-allergy/Abstract/2020/04000/Prevention_of_baker_s_asthma.4.aspx
